Giordano Christopher Thomas — SEC Form 4 filings
SEC reporting owner CIK 1871714. 7 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-21 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 2 filings — 13,455 shares, $40,087 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 1,612 shares @ $7.75 ($12,500) in TENAX THERAPEUTICS, INC., filed 2025-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | CEO, Director | 7 | 5 legs · 13,455 sh · $40,087 | — | 8 |
Form 4 filings — Giordano Christopher Thomas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Purchase (P): 6,000 @ $1.88 · Purchase (P): 4,850 @ $1.82 | EDGAR |
| 2026-07-14 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Option exercise (M): 219 @ $3.55 · Option exercise (M): 8,500 @ $5.94 · Option exercise (M): 219 (derivative) @ $0 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Purchase (P): 1,612 @ $7.75 · Purchase (P): 455 @ $7.51 · Purchase (P): 538 @ $7.59 | EDGAR |
| 2025-05-20 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 1,400,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 1,250,000 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 437 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1871714 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →